-
Achieving Health Equality
National Cancer Institute director Norman “Ned” Sharpless describes the challenge and opportunity of studying cancer disparities.
by Marci A. Landsmann
-
An Uncommon Partnership
Through the Angiosarcoma Project, researchers are partnering with patients to learn about a rare cancer.
by Ashley P. Taylor
-
Vaccinating Against Cancer
The human papillomavirus vaccine can significantly cut recipients' risk of several types of cancer. So why are vaccination rates relatively low in the U.S.?
by Brad Jones
-
The Genetics of Metastatic Cancer
The multiple tumors in patients with metastatic disease share key genetic traits, a sequencing study shows.
by Anna Azvolinsky
-
Forward Look
Drug Combo Targets Polyp GrowthStudy findings support precision approaches to risk reduction.
by Dara Chadwick
-
Forward Look
Cloning CancerScientists are testing treatments on lab-grown tumor tissue.
by Chris Palmer
-
New Tactics for Bladder Cancer
After decades without treatment advances, options for patients with bladder cancer are now more numerous.
by Kendall K. Morgan
-
Forward Look
Targeted ChemotherapyComputational and molecular biologist Sourav Bandyopadhyay discusses new ways to think about chemotherapy.
by Sue Rochman
-
Healthy Habits
Go FishWhy replacing red meat with fish may be just what the doctor ordered.
by Brenda Conaway
Cancer Talk
Understanding How High and Low Testosterone Levels Can Treat Prostate Cancer
Using high-dose testosterone after prostate cancer stops responding to androgen deprivation therapy can stop tumor growth.
by Sandra Gordon
Financial Screenings for People with CancerCancer patients say they want to be asked about their financial needs on a regular basis.
by Pamela Appea
Let Me Tell You a Story About the Power of Medical ResearchTen-year-old Michael Methner told his story about being diagnosed with optic nerve glioma at the AACR’s Rally for Medical Research.
by Cancer Research Catalyst
Aggressive Approach to Very Advanced Cancer Does Not Extend SurvivalStudy shows no benefit from treatment for cancers at very advanced stages of progression. Researchers urge end-of-life planning for these patients.
by Kyle Bagenstose